- Co-Investigator study: DANASUNIB IN BONE METS
- Attended GCP training course organized by Quintiles(India) Ltd.
- Co-Investigator IN ATLAS study : study regarding breast cancer to know duration of Tamoxifen in adjuvant setting
- Co-investigator in VORICONAZOLE-603 trial – a new antifungal drug Phase III trial.
- Co-investigator in Meropenam – new antibiotic Post marketing trial.
- Co-investigator in mesothelioma patients –MTA and Cisplatin
- Co-investigator in Breast cancer trial for new Water soluble PACLITAXEL.
- Co-investigator in Breast cancer trial – GEMCITE-TAXOL in metastatic breast cancer
- Co-investigator in new Peg-interferon Vs Roferon in chronic myeloid Leukemia patients.
- Co-investigator in Azoxifen trial for breast cancer
- Co-Investigator in Phase 3 study of Bone Metastases with Advance Cancer or Multiple Myeloma since 2007
- Co-Investigator in Phase 2 study of Breast Cancer in 2008.
- Co-Investigator in Phase 2 study of Opioid Therapy in Cancer pain since 2008.
- Co-Investigator in Phase 3 study of Renal cell carcinoma in 2009.
- Study of 50 cases of SPONTANEOUS BACTERIAL PERITONITIS: For M.D. – Internal Medicine – 1995
- Cisplatin 5- fluorouracil Vs Cisplatin Ifosfamide in recurrent \ residual Head & neck cancer: For D.M. – Oncology – 1998
PRESENTED FOLLOWING PAPERS:
- NEOADJUVANT CHEMOTHERAPY IN OSTEOSARCOMA
COAUTHORED FOLLOWING PAPERS:
- Intrapleural Bleomycin in cytology positive malignant pleural effusion
- Bisphosphanates – GCRI experience
- L-Asparaginase induced neurotoxicity – GCRI experience
- Growth pattern in treated patients of childhood ALL At Madurai — 9th biennial conference of ISMPO
- Docetaxel in metastatic breast cancer –GCRI experience
- Merkel cell carcinoma of skin – A case report
- Cisplatin-Ifosfamide in recurrent\residual head & neck cancer At Jodhpur 10th biennial conference of ISMPO